Press release
MedVi Expands Access to GLP-1 Medication - Compounded Semaglutide for Healthy Living
NEWARK, DE - MedVi Wellness, a leading telehealth provider in medical weight management, has announced the launch of its nationwide GLP-1 medication program, providing compounded semaglutide in both injectable and oral forms. Starting at $179 per month with no insurance required, MedVi [https://medvi.io] offers an affordable, physician-guided alternative to high-cost brand-name drugs such as Wegovy Registered and Ozempic Registered .
The GLP-1 medication program combines compounded semaglutide with continuous clinical oversight, 24/7 support, and fast delivery, giving patients an accessible path to sustainable weight loss backed by medical expertise.
GLP-1 Medications Driving a New Era in Weight Management
Semaglutide, a GLP-1 receptor agonist, works by reducing appetite, improving satiety, and stabilizing blood sugar levels. Clinical studies show that GLP-1 medications can help patients achieve 15-18% average weight reduction over time when combined with healthy lifestyle changes.
"GLP-1 medications like semaglutide have redefined medical weight loss," said a MedVi Wellness spokesperson. "By offering compounded semaglutide at an affordable price point with physician oversight, we are eliminating the barriers that keep most patients from accessing this transformative therapy."
Key Features of MedVi's GLP-1 Medication Program
*
Compounded Semaglutide Injections - Once-weekly dosing with pre-filled pens
*
Oral Semaglutide Tablets - A non-injectable option for daily use
*
Physician-Supervised Treatment - Personalized dosing plans from board-certified providers
*
Continuous Monitoring and Support - Unlimited check-ins and 24/7 medical access
*
Fast, Nationwide Delivery - Temperature-controlled shipping direct to patients
MedVi's program also includes GLP-1 medication for blood sugar control, benefiting patients managing type 2 diabetes while addressing weight and metabolic health together.
Addressing Drug Shortages and Rising Demand
Due to ongoing shortages of brand-name GLP-1 drugs like Wegovy Registered and Ozempic Registered , compounded semaglutide has become a vital alternative. MedVi sources exclusively from FDA-regulated, PCAB-accredited compounding pharmacies, ensuring pharmaceutical-grade standards and verified potency.
"By combining GLP-1 medication expertise with streamlined telehealth delivery, MedVi is meeting demand where traditional healthcare has fallen short," the spokesperson added. "Patients no longer need to wait months or pay thousands for care."
Why MedVi?
*
GLP-1 medications starting at $179/month
*
FDA-regulated compounding facilities and U.S.-licensed physicians
*
Transparent, no-membership pricing
*
Money-back guarantee with ongoing medical guidance
*
Service availability in all 50 U.S. states
How It Works
*
Online Medical Evaluation: Complete a secure health assessment at medvi.io [https://medvi.org/intakeform.php?uid=1&oid=5&affid=8&afid=seo&pub=5000].
*
Physician Review: A board-certified provider approves treatment if medically appropriate.
*
Medication Delivery: GLP-1 medication ships directly to the patient's home, with instructions included.
*
Ongoing Support: MedVi provides unlimited consultations, dose adjustments, and 24/7 access to licensed clinicians.
About MedVi Wellness
MedVi Wellness is a U.S.-based telehealth platform dedicated to weight loss and metabolic care through GLP-1 medications. By pairing clinical expertise with convenience and affordability, MedVi empowers patients to achieve lasting health results with doctor-led guidance and transparent pricing.
Media Contact
Company Name: MedVi Wellness
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=medvi-expands-access-to-glp1-medication-compounded-semaglutide-for-healthy-living]
Phone: (323) 690-1564
Address:131 Continental Dr. Ste 305
City: Newark
State: DE 19713
Country: United States
Website: http://medvi.io
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MedVi Expands Access to GLP-1 Medication - Compounded Semaglutide for Healthy Living here
News-ID: 4127122 • Views: …
More Releases from ABNewswire
Insulin Resistance Pipeline 2025: Therapies Under Investigation, Clinical Trials …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Insulin Resistance pipeline constitutes 8+ key companies continuously working towards developing 10+ Insulin Resistance treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Insulin Resistance Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Insulin Resistance Market.
The Insulin Resistance Pipeline report embraces…
Caliente Brands Targets Niche Spice Market with Hickory-Smoked Beef Jerky Line F …
Caliente Brands, LLC capitalizes on growing consumer demand for authentically spicy snacks with a specialized beef jerky line that puts heat first. Using only 100% USDA Approved Beef and hickory smoking techniques, the veteran-owned company offers distinctive flavors including innovative Spicy Birria alongside traditional options, all designed to deliver the brand promise that smoky and spicy meet delicious.
Caliente Brands, LLC has strategically positioned itself to serve a niche but substantial…
Manaslu Circuit Trek Offers the Real Taste of Wilderness Adventure in the Himala …
Kathmandu, Nepal - Peace Nepal Treks announces expanded departures for the Manaslu Circuit Trek, a high Himalayan journey known for raw landscapes, cultural depth, and challenging terrain. This route delivers a true wilderness experience for trekkers seeking remote adventure beyond crowded trails.
The Manaslu Circuit Trek encircles Mount Manaslu at 8,163 meters, the eighth highest peak on Earth. The trail crosses Larke Pass at 5,106 meters and moves through steep gorges,…
Custom Cardboard Boxes: Complete Buyer Guide
Image: https://www.abnewswire.com/upload/2026/02/0f0fee39afaa0d25711f34ee831a6f6f.jpg
Packaging protects merchandise and shapes first impressions. It additionally impacts transport value, and consumers agree with it. In today's market, brands need packaging that is strong, flexible, and affordable. This is where custom cardboard packing boxes play a crucial role.
Custom cardboard boxes [https://www.thecustomboxes.com/cardboard-boxes/] are used by small groups and large brands alike. They paint retail shelves, online orders, and warehouse garages. They are easy to print, smooth to recycle,…
More Releases for MedVi
Medvi Expands Doctor-Led GLP-1 Weight Management Services Through Its Telehealth …
Image: https://www.abnewswire.com/upload/2026/02/6d63e0b636f1f82b08fc0e1f4b63d66e.jpg
Medvi, a telehealth platform providing access to prescription GLP-1 medications, has expanded its doctor-led weight management services through its online platform, en-medvi.com. The service connects patients with licensed clinicians for virtual evaluation and, when appropriate, provides access to GLP-1 treatments such as semaglutide and tirzepatide delivered directly to the patient's home.
The Medvi [https://en-medvi.com/] platform was developed to make medical weight management more accessible by combining telehealth consultations, digital patient…
Semaglutide vs. Tirzepatide: MEDVi Launches Physician-Led Program to Help Patien …
MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program designed to help patients navigate the decision between semaglutide and tirzepatide, two GLP-1 medications at the center of the weight loss conversation in 2026
Image: https://www.abnewswire.com/upload/2026/01/b073060257f5a89d5da79f605bbb6ccb.jpg
Disclosure: This announcement is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved. This release may include links or references for which the issuer may…
MEDVi Expands Access to Semaglutide Online With Updated Program Trusted by 100,0 …
MEDVi, a telehealth platform serving more than 100,000 patients, today announced continued nationwide momentum as Americans seek more convenient, clinician-supervised access to GLP-1 weight-loss medications, including semaglutide, through an all-inclusive online program designed to reduce friction, improve support, and set a higher bar for patient experience.
Disclosure: This announcement is for informational purposes only and does not constitute medical advice. Compounded semaglutide is not FDA-approved. This release may include links or…
My Start GLP 1 Reviews: The GLP 1 That is Changing the Way America loss Weight
In the modern era of health innovation, few breakthroughs have generated as much excitement as My Start GLP 1. In 2025, it has rapidly become one of the most talked-about doctor-supervised weight loss programs in the United States. With thousands of verified patient success stories, My Start GLP 1 has positioned itself as more than a trend-it is a science-backed revolution changing how we understand metabolism, hunger, and sustainable fat…
MedVi Unveils Its Cheaper Compounded GLP-1 Weight Management Medication Alternat …
Affordable telehealth platform offers cost-saving GLP-1 medication options for Americans seeking to manage weight without breaking the bank-physician-supervised care starting at just $179 per month.
Image: https://www.abnewswire.com/upload/2025/10/58a28bbefc869a8ec591ab5122e76187.jpg
United States - As brand-name GLP-1 medications like Wegovy and Ozempic continue to carry monthly costs exceeding $1,000 without insurance, MedVi today released a comprehensive overview of cheaper, compounded alternatives available to American patients. With over 500,000 patients served, MedVi addresses the critical question: Which…
MEDVi Personalized GLP-1 Medication Review - Is This the Future of Weight Loss a …
MEDVi Personalized GLP-1 Medication Review - Is This the Future of Weight Loss and Diabetes Management?
Introduction: Why Everyone's Talking About Personalized GLP-1 Medications
In today's fast-moving world of health innovation, one major trend is dominating Google searches and health forums alike-personalized GLP-1 medications. With the rise of obesity, prediabetes, and insulin resistance across all age groups, more people than ever are looking for smarter, science-backed solutions that deliver real results without…
